Apart from cross-sectional and case–control studies, which inherently cannot prove causal relationships, a prospective cohort study reported that higher serum TNF-α levels at baseline in apparently healthy participants were associated with increased adjusted risk of developing NAFLD after 4 years of follow-up [52]. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.